drugset / Trial / NCT00114049
Dental Pain (Following Third Molar Tooth Extraction) Study
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the effectiveness of GW406381 (a COX-2 inhibitor) in treating the signs and symptoms of dental pain following third molar tooth extraction.
Timeline
- Start
- 2004-12
- Primary completion
- 2005-04
- Completion
- 2005-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GW406381 | Small molecule | 10 mg | Oral |
| Subject | GW406381 | Small molecule | 25 mg | Oral |
| Subject | GW406381 | Small molecule | 50 mg | Oral |
| Subject | GW406381 | Small molecule | 70 mg | Oral |